BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 31279780)

  • 1. PLAGL2 and POFUT1 are regulated by an evolutionarily conserved bidirectional promoter and are collaboratively involved in colorectal cancer by maintaining stemness.
    Li D; Lin C; Li N; Du Y; Yang C; Bai Y; Feng Z; Su C; Wu R; Song S; Yan P; Chen M; Jain A; Huang L; Zhang Y; Li X
    EBioMedicine; 2019 Jul; 45():124-138. PubMed ID: 31279780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. POFUT1 and PLAGL2 gene pair linked by a bidirectional promoter: the two in one of tumour progression in colorectal cancer?
    Germot A; Maftah A
    EBioMedicine; 2019 Aug; 46():25-26. PubMed ID: 31378697
    [No Abstract]   [Full Text] [Related]  

  • 3. Overexpressed PLAGL2 transcriptionally activates Wnt6 and promotes cancer development in colorectal cancer.
    Li N; Li D; Du Y; Su C; Yang C; Lin C; Li X; Hu G
    Oncol Rep; 2019 Feb; 41(2):875-884. PubMed ID: 30535429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weighted gene coexpression analysis indicates that PLAGL2 and POFUT1 are related to the differential features of proximal and distal colorectal cancer.
    Lv Y; Xie B; Bai B; Shan L; Zheng W; Huang X; Zhu H
    Oncol Rep; 2019 Dec; 42(6):2473-2485. PubMed ID: 31638246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oncogenic function of PLAGL2 is mediated via ASCL2 and IGF2 and a Wnt-independent mechanism in colorectal cancer.
    Fischer AD; Veronese Paniagua DA; Swaminathan S; Kashima H; Rubin DC; Madison BB
    Am J Physiol Gastrointest Liver Physiol; 2023 Aug; 325(2):G196-G211. PubMed ID: 37310750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression.
    Zhao Z; Shelton SD; Oviedo A; Baker AL; Bryant CP; Omidvarnia S; Du L
    J Exp Clin Cancer Res; 2020 Feb; 39(1):41. PubMed ID: 32087738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleomorphic adenoma gene like-2 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human colorectal adenocarcinoma.
    Wang YP; Guo PT; Zhu Z; Zhang H; Xu Y; Chen YZ; Liu F; Ma SP
    Oncol Rep; 2017 Apr; 37(4):1961-1970. PubMed ID: 28259923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLAGL2 promotes epithelial-mesenchymal transition and mediates colorectal cancer metastasis via β-catenin-dependent regulation of ZEB1.
    Wu L; Zhou Z; Han S; Chen J; Liu Z; Zhang X; Yuan W; Ji J; Shu X
    Br J Cancer; 2020 Feb; 122(4):578-589. PubMed ID: 31827238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas signaling induces stemness properties in colorectal cancer by regulation of Bmi1.
    Chen J; Wang Y; Zhuo L; Liu Z; Liu T; Li W; Cai Y; Zheng H
    Mol Carcinog; 2017 Oct; 56(10):2267-2278. PubMed ID: 28543447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLAGL2 promotes the stemness and is upregulated by transcription factor E2F1 in human lung cancer.
    Lin Y; Lin P; Guo W; Huang J; Xu X; Zhuang X
    Environ Toxicol; 2023 Mar; 38(4):941-949. PubMed ID: 36620907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-449a suppresses cell migration and invasion by targeting PLAGL2 in breast cancer.
    Xu B; Zhang X; Wang S; Shi B
    Pathol Res Pract; 2018 May; 214(5):790-795. PubMed ID: 29653747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Jun/miR-22/HuR regulatory axis contributes to tumourigenesis in colorectal cancer.
    Liu Y; Chen X; Cheng R; Yang F; Yu M; Wang C; Cui S; Hong Y; Liang H; Liu M; Zhao C; Ding M; Sun W; Liu Z; Sun F; Zhang C; Zhou Z; Jiang X; Chen X
    Mol Cancer; 2018 Jan; 17(1):11. PubMed ID: 29351796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
    Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
    Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. POFUT1 promotes colorectal cancer development through the activation of Notch1 signaling.
    Du Y; Li D; Li N; Su C; Yang C; Lin C; Chen M; Wu R; Li X; Hu G
    Cell Death Dis; 2018 Sep; 9(10):995. PubMed ID: 30250219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-214-3p targets the PLAGL2-MYH9 axis to suppress tumor proliferation and metastasis in human colorectal cancer.
    Zhou Z; Wu L; Liu Z; Zhang X; Han S; Zhao N; Bao H; Yuan W; Chen J; Ji J; Shu X
    Aging (Albany NY); 2020 May; 12(10):9633-9657. PubMed ID: 32413870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DJ-1 promotes colorectal cancer progression through activating PLAGL2/Wnt/BMP4 axis.
    Zhou J; Liu H; Zhang L; Liu X; Zhang C; Wang Y; He Q; Zhang Y; Li Y; Chen Q; Zhang L; Wang K; Bu Y; Lei Y
    Cell Death Dis; 2018 Aug; 9(9):865. PubMed ID: 30158634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studying the mechanism of PLAGL2 overexpression and its carcinogenic characteristics based on 3'-untranslated region in colorectal cancer.
    Su C; Li D; Li N; Du Y; Yang C; Bai Y; Lin C; Li X; Zhang Y
    Int J Oncol; 2018 May; 52(5):1479-1490. PubMed ID: 29512763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of ZG16 is regulated by miR-196a and contributes to stemness and progression of colorectal cancer.
    Chen X; Du P; She J; Cao L; Li Y; Xia H
    Oncotarget; 2016 Dec; 7(52):86695-86703. PubMed ID: 27880730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway.
    Yu J; Han Z; Sun Z; Wang Y; Zheng M; Song C
    J Exp Clin Cancer Res; 2018 Sep; 37(1):222. PubMed ID: 30201010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.